反応式
[S:1]([C:4]1[CH:22]=[CH:21][C:7]2[N:8]=[C:9]([NH:11][C:12](=[O:20])[O:13][C:14]3[CH:19]=CC=CC=3)[S:10][C:6]=2[CH:5]=1)[C:2]#[N:3].[N:23]1(CCN)[CH2:28][CH2:27][O:26][CH2:25][CH2:24]1>>[S:1]([C:4]1[CH:22]=[CH:21][C:7]2[N:8]=[C:9]([NH:11][C:12](=[O:20])[O:13][CH2:14][CH2:19][N:23]3[CH2:28][CH2:27][O:26][CH2:25][CH2:24]3)[S:10][C:6]=2[CH:5]=1)[C:2]#[N:3]参加物
3
実験手順
The 2-morpholin-4-ylethyl (6-thiocyanato-1,3-benzothiazol-2-yl)carbamate was prepared according to the method described in Example 9c, but using 654 mg of phenyl (6-thiocyanato-1,3-benzothiazol-2-yl)carbamate and 0.27 cm3 of 2-morpholin-4-ylethanamine. The residue obtained is chromatographed on an Analogix cartridge of 40 g of silica 15-40 μm, elution being carried out with a gradient of dichloromethane then 95/5 dichloromethane/methanol. 729 mg of 2-morpholin-4-ylethyl (6-thiocyanato-1,3-benzothiazol-2-yl)carbamate are thus obtained in the form of a white solid, the characteristics of which are as follows:
後処理
- customThe 2-morpholin-4-ylethyl (6-thiocyanato-1,3-benzothiazol-2-yl)carbamate was prepared
- customThe residue obtained
- customis chromatographed on an Analogix cartridge of 40 g of silica 15-40 μm, elution
出典と根拠
- ORDレコード
- ord-88ba77e7c48542979ff10be620b962a1
- 出典データセット
- uspto-grants-2016_04
- 特許番号
- US09321777B2
関連ノート
読み込み中…